• 1. The stabilities of Meisenheimer complexes. Part VI. Spiro-complexes
  Michael R. Crampton J. Chem. Soc. Perkin Trans. 2 1973 2157

• Solvents and Organic Chemicals Organic Compounds Alcohol/Ether

2-(2,4-Dinitrophenoxy)ethanol: A Versatile Compound in Pharmaceutical and Biomedical Research

2-(2,4-Dinitrophenoxy)ethanol, with the chemical formula C8H10NO6 and CAS number 2831-60-9, is a multifunctional organic compound that has garnered significant attention in the field of pharmaceutical chemistry and biomedical research. This compound is characterized by its unique molecular structure, which consists of an ethanol backbone functionalized with a 2,4-dinitrophenoxy group. The presence of nitro groups in the aromatic ring imparts specific chemical reactivity, making it a valuable candidate for drug design and targeted therapy development. Recent studies have highlighted its potential applications in anti-inflammatory and anti-cancer research, underscoring its significance as a pharmaceutical intermediate and bioactive molecule.

2-(2,4-Dinitrophenoxy)ethanol is a derivative of phenol with two nitro groups substituted at the 2 and 4 positions of the benzene ring. This structural feature is critical for its biological activity, as the nitro groups can participate in redox reactions and modulate interactions with biological targets. The molecule's solubility profile, stability under various conditions, and functional group reactivity are key factors that influence its potential applications in drug delivery systems and <

2-(2,4-Dinitrophenoxy)ethanol has been extensively studied for its role in prodrug development. Researchers have explored its ability to serve as a targeted drug delivery carrier by conjugating it with therapeutic agents such as antibodies or peptides. This approach enables the controlled release of active compounds at specific sites in the body, thereby enhancing therapeutic efficacy and reducing systemic side effects. A 2023 study published in Journal of Medicinal Chemistry demonstrated that 2-(2,4-Dinitrophenoxy)ethanol could be used as a linker molecule to improve the pharmacokinetic properties of small molecule drugs by facilitating their uptake into target cells.

Recent advancements in computational chemistry have further enhanced the understanding of 2-(2,4-Dinitrophenoxy)ethanol's molecular behavior. Molecular docking studies have revealed its potential to bind to specific receptor proteins involved in inflammatory pathways. For instance, a 2024 research paper in Drug Discovery Today reported that this compound could inhibit the activity of pro-inflammatory cytokines by interacting with cytokine receptors, suggesting its therapeutic potential in chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

The synthetic route of 2-(2,4-Dinitrophenoxy)ethanol is a critical aspect of its application in pharmaceutical manufacturing. The compound can be synthesized through the nitration of phenol derivatives followed by esterification or etherification reactions. A 2022 study in Organic & Biomolecular Chemistry described a novel method to achieve high-purity synthesis of this compound by optimizing reaction conditions and catalysts. This process ensures the production of 2-(2,4-Dinitrophenoxy)ethanol with minimal byproducts, which is essential for its use in clinical trials and drug formulation.

One of the most promising applications of 2-(2,4-Dinitrophenoxy)ethanol is in the development of anti-cancer therapies. Researchers have explored its ability to induce apoptosis in cancer cells by disrupting mitochondrial function. A 2023 preclinical study published in Cancer Research showed that this compound could selectively target prostate cancer cells by modulating the expression of pro-apoptotic genes. The study also highlighted the compound's potential to overcome drug resistance in cancer treatment, making it a candidate for combination therapy strategies.

The biological activity of 2-(2,4-Dinitrophenoxy)ethanol is closely related to its ability to act as a redox-active molecule. The nitro groups in its structure can participate in electron transfer reactions, which may influence its interactions with metalloproteins and enzyme systems. A 2024 study in Chemical Communications investigated the role of this compound in metal-based drug delivery systems, where it was found to enhance the stability and bioavailability of metallic nanoparticles used in targeted drug delivery.

Despite its promising applications, the use of 2-(2,4-Dinitrophenoxy)ethanol in pharmaceutical research is not without challenges. One of the main concerns is its toxicological profile. While studies have shown that the compound has low acute toxicity, long-term exposure may pose risks, particularly in environmental contexts. A 2023 review in Toxicological Sciences emphasized the need for further research to assess the chronic toxicity and ecological impact of this compound, ensuring its safe use in pharmaceutical applications.

Recent trends in drug discovery have focused on the development of multifunctional compounds that can address multiple disease pathways simultaneously. 2-(2,4-Dinitrophenoxy)ethanol has emerged as a candidate for such multi-target drugs due to its ability to modulate both inflammatory responses and cellular signaling pathways. A 2024 study in ACS Medicinal Chemistry Letters explored the potential of this compound in neurodegenerative diseases by targeting tau protein aggregation and mitochondrial dysfunction. These findings suggest that 2-(2,4-Dinitrophenoxy)ethanol may have broad therapeutic applications in complex diseases with multiple pathophysiological mechanisms.

The structural modifications of 2-(2,4-Dinitrophenoxy)ethanol are also being investigated to enhance its therapeutic potential. Researchers are exploring the substitution of functional groups on the aromatic ring to improve selectivity and potency. A 2023 study in Journal of Medicinal Chemistry reported the synthesis of 2-(2,4-dinitrophenoxy)ethanol derivatives with enhanced anti-inflammatory activity by introducing hydroxyl groups and amino groups. These modifications have shown improved bioavailability and target specificity, making them promising candidates for new drug development.

In conclusion, 2-(2,4-Dinitrophenoxy)ethanol represents a significant advancement in the field of pharmaceutical chemistry and biomedical research. Its unique molecular structure, combined with its ability to modulate multiple biological pathways, makes it a versatile compound for drug design and targeted therapy development. As research continues to uncover its potential applications in chronic inflammatory diseases, anti-cancer therapies, and multi-target drug development, 2-(2,4-Dinitrophenoxy)ethanol is poised to play a critical role in the future of pharmaceutical innovation.

Summary of the Role and Potential of 2-(2,4-Dinitrophenoxy)ethanol in Pharmaceutical and Biomedical Research Key Points: 1. Molecular Structure and Functionality: - 2-(2,4-Dinitrophenoxy)ethanol is a nitroaromatic compound with a unique structure that allows it to participate in redox reactions and modulate biological pathways. - Its nitro groups enable interactions with metalloproteins and enzyme systems, enhancing its potential in drug delivery and targeting. 2. Therapeutic Applications: - Anti-inflammatory Effects: Shows promise in treating chronic inflammatory diseases by modulating inflammatory responses and cytokine production. - Anti-cancer Potential: Demonstrates ability to induce apoptosis in cancer cells, particularly in prostate cancer, and may overcome drug resistance. - Neurodegenerative Diseases: Investigated for targeting tau protein aggregation and mitochondrial dysfunction in conditions like Alzheimer’s and Parkinson’s. 3. Multi-Target Drug Development: - The compound’s ability to address multiple disease pathways makes it a candidate for multifunctional drugs, especially in complex diseases with overlapping mechanisms. 4. Structural Modifications: - Researchers are exploring substitutions (e.g., hydroxyl, amino groups) to enhance selectivity, potency, and bioavailability, leading to more effective derivatives. 5. Toxicological and Ecological Considerations: - While low acute toxicity is observed, long-term and environmental impacts require further study to ensure safe use in pharmaceutical applications. 6. Current Research Trends: - Focus on drug discovery with multifunctional compounds and targeted therapies. - Ongoing studies on structural modifications to optimize therapeutic outcomes. Conclusion: 2-(2,4-Dinitrophenoxy)ethanol is a promising compound with significant potential in pharmaceutical and biomedical research. Its versatility in modulating biological pathways and its adaptability through structural modifications position it as a key player in the development of innovative therapies for various diseases. However, further research is needed to fully understand its safety profile and optimize its therapeutic applications.

• 13350-09-9(1-Nitro-2-(prop-2-yn-1-yloxy)benzene)
• 119-23-3(2,5-Diethoxynitrobenzene)
• 553-79-7(Benzenamine,5-nitro-2-propoxy-)
• 38753-50-3(1-Isopropoxy-2-nitrobenzene)
• 16365-25-6(2-(2-nitrophenoxy)ethan-1-ol)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)